The role of imaging and other diagnostic approaches in COVID-19

The role of imaging and other diagnostic approaches in COVID-19

Authors

  • Rohma Shammus Department of Medicine, St. George’s University of London
  • Samiha Mahbub Department of Medicine, St. George’s University of London
  • Muhammad Atif Rauf Department of Medicine, St. George’s University of London
  • Amer Harky a:1:{s:5:"en_US";s:22:"Cardiothoracic Surgery";}

Keywords:

COVID-19, Biomarkers

Abstract

As the COVID 19 pandemic develops across the globe, a large amount of literature has been written about the different ways in which we can diagnose and investigate someone suspected of being infected with the new coronavirus. Many approaches highlight the importance of using reverse transcriptase polymerase chain reaction (RT-PCR) used in conjunction with computed tomography (CT) scans. Whilst CT scans have been shown to be useful, there are multiple risks associated with them, for example radiation exposure and the transmission risk associated with repeated use of a CT suite. Therefore, it is important to analyse their diagnostic ability and limitations and to consider other methods of diagnosing COVID 19. Additionally, RT-PCR testing can have significant rates of false negatives, indicating the importance of taking a more comprehensive diagnostic approach. Here, we aim to review and analyse this literature to compare RT-PCR, serum inflammatory biomarkers, chest radiographs, ultrasound and chest CT scanning as methods of diagnosing COVID 19, particularly in asymptomatic patients.

References

Tan W, Zhao X, Ma X, et al. Notes from the Field A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019 − 2020. China CDC Weekly. 2020;2(4):61-62.

Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA - Journal of the American Medical Association. 2020. doi:10.1001/jama.2020.3786

World Health Organisation. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117. Accessed April 27, 2020.

Handbook of COVID-19 Prevention and Treatment | ALNAP. https://www.alnap.org/help-library/handbook-of-covid-19-prevention-and-treatment. Accessed May 1, 2020.

Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. European Radiology. March 2020:1-9. doi:10.1007/s00330-020-06801-0

Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology. April 2020:201343. doi:10.1148/radiol.2020201343

Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. February 2020:200432. doi:10.1148/radiol.2020200432

Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. February 2020:200642. doi:10.1148/radiol.2020200642

Yu F, Yan L, Wang N, et al. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. March 2020. doi:10.1093/cid/ciaa345

Lin C, Xiang J, Yan M, Li H, Huang S, Shen C. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). De Gruyter. February 2020. doi:10.1515/cclm-2020-0187

Henry BM, Oliveira MHSD, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. De Gruyter. March 2020. doi:10.1515/cclm-2020-0369

Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. Journal of Medical Virology. April 2020: jmv.25871. doi:10.1002/jmv.25871

What is the role of imaging and biomarkers within the current testing strategy for the diagnosis of Covid-19? - CEBM. https://www.cebm.net/covid-19/what-is-the-role-of-imaging-and-biomarkers-within-the-current-testing-strategy-for-the-diagnosis-of-covid-19/. Accessed May 1, 2020.

Wong HYF, Lam HYS, Fong AH-T, et al. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients. Radiology. March 2019:201160. doi:10.1148/radiol.2020201160

Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032

Jacobi A, Chung M, Bernheim A, Eber C. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review. Clinical Imaging. 2020; 64:35-42. doi:10.1016/j.clinimag.2020.04.001

Buonsenso D, Piano A, Raffaelli F, Bonadia N, de Gaetano Donati K, Franceschi F. Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: A case report and potential applications during COVID-19 outbreak. European Review for Medical and Pharmacological Sciences. 2020;24(5):2776-2780. doi:10.26355/eurrev_202003_20549

Lu W, Zhang S, Chen B, et al. A Clinical Study of Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound. Ultraschall in der Medizin - European Journal of Ultrasound. April 2020. doi:10.1055/a-1154-8795

Smith MJ, Hayward SA, Innes SM, Miller ASC. Point‐of‐care lung ultrasound in patients with COVID‐19 – a narrative review. Anaesthesia. April 2020: anae.15082. doi:10.1111/anae.15082

Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. February 2020:200463. doi:10.1148/radiol.2020200463

Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. American Journal of Roentgenology. 2020;214(5):1072-1077. doi:10.2214/AJR.20.22976

Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology. February 2020:200370. doi:10.1148/radiol.2020200370

Wang Y, Dong C, Hu Y, et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. March 2020:200843. doi:10.1148/radiol.2020200843

Ooi GC, Khong PL, Müller NL, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004;230(3):836-844. doi:10.1148/radiol.2303030853

Downloads

Published

07-09-2020

Issue

Section

REVIEWS/FOCUS ON - SPECIAL COVID19

How to Cite

1.
Shammus R, Mahbub S, Rauf MA, Harky A. The role of imaging and other diagnostic approaches in COVID-19 . Acta Biomed [Internet]. 2020 Sep. 7 [cited 2024 Jul. 20];91(3):e2020019. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9822